HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Market cap $2.4B
Insiders sold $3.1M net in the last 90 days ·1 seller, 0 buyers· 5 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 18, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.0M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Sep 18, 2026
Budur Kumar
Harmony Biosciences Holdings, Inc. (HRMY) has 14 SEC Form 4 filings (45 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Sep 18, 2026.
Inside the rolling window, 3 insiders at Harmony Biosciences Holdings, Inc. reported no open-market purchases and 10 open-market sales totaling $6.0M. The most active filer is CHIEF MEDICAL OFFICER Budur Kumar with 5 filings. Insiders have net sold $3.1M over the trailing 6 months. The most recent open-market filing is a sale of 1,800 shares by CHIEF MEDICAL OFFICER Budur Kumar, dated Sep 16, 2026, worth $77K.
- Industry:Biotechnology
- CEO:Jeffrey Dayno
- Employees:293
- HQ:Plymouth Meeting, PA, US
- IPO:2020-08-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CHIEF MEDICAL OFFICER | Sale | 1,800 | $77K | Sep 18 | -3.7% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 800 | $34K | Sep 18 | -3.7% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 35,852 | $1.5M | Sep 18 | -3.7% | SEC ↗ | |
Budur KumarFirst filing | CHIEF MEDICAL OFFICER | Sale | 5,500 | $231K | Sep 9 | -2.7% | SEC ↗ |
Budur KumarFirst filing | CHIEF MEDICAL OFFICER | Sale | 28,454 | $1.2M | Sep 9 | -2.7% | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 3,746 | $139K | Jan 28 | +9.9% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 20,961 | $753K | Jan 20 | +12.7% | SEC ↗ | |
Dayno Jeffrey M.First filing | PRESIDENT, CEO | Sale | 25,933 | $1.0M | Dec 17 | +4.4% | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 20,000 | $791K | Dec 9 | — | SEC ↗ | |
Kapadia SandipFirst filing | CHIEF FINANCIAL OFFICER | Sale | 3,427 | $120K | Nov 25 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does HRMY have?
Harmony Biosciences Holdings, Inc. (HRMY) has 14 SEC Form 4 filings (45 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Sep 18, 2026.
When was the most recent SEC Form 4 filing for HRMY?
The most recent Form 4 filing for HRMY on Tracefour is dated Sep 18, 2026.
Who is the most active insider at HRMY?
The most active SEC Form 4 filer at HRMY in the rolling window is CHIEF MEDICAL OFFICER Budur Kumar, with 5 filings.
What is the net insider flow at HRMY over the last 6 months?
Over the trailing 180 days, insiders at HRMY have net sold $3.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at HRMY in the current window?
Inside the rolling window, insiders at HRMY bought $0 and sold $6.0M based on SEC Form 4 filings.
Can I get alerts for HRMY insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Harmony Biosciences Holdings, Inc. (HRMY). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Harmony Biosciences Holdings, Inc. is in the Healthcare sector.